| ||
Name: 4-methyl-5-(6-{[4-(methylsulfonyl)piperazin-1-yl]methyl}-4-morpholin-4-ylthieno[3,2-d]pyrimidin-2-yl)pyrimidin-2-amine | ||
Formula: C21 H28 N8 O3 S2 | ||
Weight: 504.629 | ||
SMILES: "Cc1nc(N)ncc1c2nc3cc(CN4CCN(CC4)[S](C)(=O)=O)sc3c(n2)N5CCOCC5" | ||
Spacial conformation based on PDB
?. Also present on 3l17 |
RESIDUE JZY 62 CONECT C1 3 N2 C6 N10 CONECT N2 2 C1 C3 CONECT C3 3 N2 N4 C16 CONECT N4 2 C3 C5 CONECT C5 3 N4 C6 C9 CONECT C6 3 C1 C5 S7 CONECT S7 2 C6 C8 CONECT C8 3 S7 C9 C24 CONECT C9 3 C5 C8 H9 CONECT N10 3 C1 C11 C15 CONECT C11 4 N10 C12 H11 H11A CONECT C12 4 C11 O13 H12 H12A CONECT O13 2 C12 C14 CONECT C14 4 O13 C15 H14 H14A CONECT C15 4 N10 C14 H15 H15A CONECT C16 3 C3 C17 C21 CONECT C17 3 C16 N18 H17 CONECT N18 2 C17 C19 CONECT C19 3 N18 N20 N23 CONECT N20 2 C19 C21 CONECT C21 3 C16 N20 C22 CONECT C22 4 C21 H22 H22A H22B CONECT N23 3 C19 HN23 HN2A CONECT C24 4 C8 N25 H24 H24A CONECT N25 3 C24 C26 C30 CONECT C26 4 N25 C27 H26 H26A CONECT C27 4 C26 N28 H27 H27A CONECT N28 3 C27 C29 S31 CONECT C29 4 N28 C30 H29 H29A CONECT C30 4 N25 C29 H30 H30A CONECT S31 4 N28 O32 O33 C34 CONECT O32 1 S31 CONECT O33 1 S31 CONECT C34 4 S31 H34 H34A H34B CONECT H9 1 C9 CONECT H11 1 C11 CONECT H11A 1 C11 CONECT H12 1 C12 CONECT H12A 1 C12 CONECT H14 1 C14 CONECT H14A 1 C14 CONECT H15 1 C15 CONECT H15A 1 C15 CONECT H17 1 C17 CONECT H22 1 C22 CONECT H22A 1 C22 CONECT H22B 1 C22 CONECT HN23 1 N23 CONECT HN2A 1 N23 CONECT H24 1 C24 CONECT H24A 1 C24 CONECT H26 1 C26 CONECT H26A 1 C26 CONECT H27 1 C27 CONECT H27A 1 C27 CONECT H29 1 C29 CONECT H29A 1 C29 CONECT H30 1 C30 CONECT H30A 1 C30 CONECT H34 1 C34 CONECT H34A 1 C34 CONECT H34B 1 C34 END HET JZY 62 HETNAM JZY 4-methyl-5-(6-{[4-(methylsulfonyl)piperazin-1-yl]methyl HETNAM 2 JZY }-4-morpholin-4-ylthieno[3,2-d]pyrimidin-2-yl)pyrimidin HETNAM 3 JZY -2-amine FORMUL JZY C21 H28 N8 O3 S2
This OCA
MONOMER page uses Jmol, developed by the Jmol Development Team (color reference)
|